Orion Pharma (DHA:ORIONPHARM) FCF Margin % : -9.79% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Orion Pharma's Free Cash Flow for the three months ended in Dec. 2024 was BDT-84 Mil. Orion Pharma's Revenue for the three months ended in Dec. 2024 was BDT860 Mil. Therefore, Orion Pharma's FCF Margin % for the quarter that ended in Dec. 2024 was -9.79%.

As of today, Orion Pharma's current FCF Yield % is -1.03%.

The historical rank and industry rank for Orion Pharma's FCF Margin % or its related term are showing as below:

DHA:ORIONPHARM' s FCF Margin % Range Over the Past 10 Years
Min: -15.58 Med: 1.15 Max: 25.18
Current: -1.02

During the past 12 years, the highest FCF Margin % of Orion Pharma was 25.18%. The lowest was -15.58%. And the median was 1.15%.

DHA:ORIONPHARM's FCF Margin % is ranked worse than
54.81% of 416 companies
in the Utilities - Independent Power Producers industry
Industry Median: 1.805 vs DHA:ORIONPHARM: -1.02

Orion Pharma FCF Margin % Historical Data

The historical data trend for Orion Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma FCF Margin % Chart

Orion Pharma Annual Data

Trend

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Margin %

Get a 7-Day Free Trial

4.43

-15.56

-15.58

-9.81

-2.72

Orion Pharma Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-31.63	-22.19	31.17	-25.78	-9.79

Competitive Comparison of Orion Pharma's FCF Margin %

For the Utilities - Independent Power Producers subindustry, Orion Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Pharma's FCF Margin % Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Orion Pharma's FCF Margin % falls into.

Orion Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Orion Pharma's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-289.065	/	10620.866
	=	-2.72 %

Orion Pharma's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-84.191	/	860.395
	=	-9.79 %

Orion Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Orion Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208

Website

https://www.orionpharmabd.com

Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines